DNA Earnings Date: Nov 5, 2026 (Estimated) — Ginkgo Bioworks Holdings, Inc.
NYSE · Healthcare · Biotechnology
Updated
When is DNA's next earnings date?
Ginkgo Bioworks Holdings, Inc. (DNA) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.58 on revenue of $21.5M.
How did DNA do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Ginkgo Bioworks Holdings, Inc. posted EPS of -$0.92 versus the -$0.90 estimate, a miss of 31.4%. Revenue was $20.2M against a $24.1M estimate. The stock's 1-day post-earnings move was -9.3%.
How much does DNA stock move after earnings?
DNA beat EPS estimates in 1 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 14.8% (up or down) in the day after earnings.
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | -0.90 | -0.92 | -31.43% | $20.2M | ❌ Miss | -9.29% | -23.05% | -25.83% |
| 2026-05-07 | Q1 2026 | -1.34 | -1.39 | -3.73% | $19.5M | ❌ Miss | -13.47% | -23.93% | -21.61% |
| 2026-02-26 | Q4 2025 | -1.39 | -1.41 | -1.44% | $33.3M | ❌ Miss | -30.48% | -29.56% | -38.93% |
| 2025-11-06 | Q3 2025 | -1.24 | -1.45 | -16.94% | $38.8M | ❌ Miss | -20.80% | -29.20% | -16.81% |
| 2025-02-25 | Q4 2024 | -1.30 | -2.00 | -53.85% | $43.8M | ❌ Miss | -11.47% | -21.09% | -35.37% |
| 2024-11-12 | Q3 2024 | -2.71 | -1.08 | +60.15% | $89.0M | ✅ Beat | +2.50% | -23.12% | +23.12% |
| 2024-02-29 | Q4 2023 | -4.00 | -4.40 | -10.00% | $34.8M | ❌ Miss | -15.13% | -21.05% | -26.32% |
| 2023-11-08 | Q3 2023 | -3.60 | -6.40 | -77.78% | $55.4M | ❌ Miss | -15.44% | +4.70% | -8.72% |
Showing last 8 quarters.